Drugs / Niferex
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 1/2 | NCT02656225 Comparator | Mar 2015 → Jun 2016 | — | The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine | Unknown | No outcome recorded |
| Phase 4 | NCT00511901 Comparator | Nov 2005 → May 2008 | anemia | University of Medicine and Dentistry of New Jersey | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Niferex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02656225 ↗ |
| Route | Oral | “The participants in control group receive Polysaccharide Iron Complex(Niferex)(150mg per tablet, once daily) orally after breakfast over 4 weeks.” NCT02656225 ↗ |